COMPARISON OF EPIDURAL(OUTSIDE SPINAL CORD)DEXAMETHASONE (STEROID)AND EPIDURAL MORPHINE(OPIOID)FOR POST OPERATIVE PAIN RELIEF IN TOTAL ABDOMINAL HYSTERECTOMY(REMOVAL OF UTERUS)
- Conditions
- Medical and Surgical,
- Registration Number
- CTRI/2021/11/038020
- Lead Sponsor
- VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS
- Brief Summary
60 patients undergoing total abdominal hysterectomy under epidural anaeshesia will be recruited for the study. They will be randomized into two groups. One group will receive 4 mg morphine in 2 ml normal saline as an additive to 8 ml 0.5 % bupivacaine and the other group will receive 8 mg dexamethasone as an additive to 8 ml 0.5 % bupivacaine. The duration of postoperative analgesia will be assessed using visual analogue scale and the time of administration of first rescue analgesic will be noted and compared in both groups. Adverse effects will also be monitored.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 60
ASA 1 AND 2 PATIENTS UNDERGOING TOTAL ABDOMINAL HYSTERECTOMY UNDER EPIDURAL ANESTHESIA.
PATIENTS WHO ARE NOT WILLING FOR TRIAL, ALLERGIC TO DRUGS USED IN THE TRIAL, ASA GRADE 3 & 4, PATIENTS WHO ARE CONTRAINDICATED FOR EPIDURAL ANESTHESIA, PATIENTS REQUIRING GENERAL ANESTHESIA.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TO DETERMINE THE POSTOPERATIVE ANALGESIC EFFICACY OF EPIDURAL DEXAMETHASONE AND EPIDURAL MORHINE AS ADDITIVES TO BUPIVACAINE USING VISUAL ANALOG SCALE POST OPERATIVE ANALGESIA WILL BE ASSESSED UPTO 24 HOURS
- Secondary Outcome Measures
Name Time Method TO ASSESS THE ADVERSE EFFECTS OF EPIDURAL DEXAMETHASONE AND MORPHINE ADVERSE EFFECTS WILL BE MONITORED FOR 24 HOURS
Trial Locations
- Locations (1)
VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS
🇮🇳Salem, TAMIL NADU, India
VINAYAKA MISSIONS KIRUPANANDA VARIYAR MEDICAL COLLEGE AND HOSPITALS🇮🇳Salem, TAMIL NADU, IndiaPRIYANKA CHANDRANPrincipal investigator9789092597CPRIYANKA55@GMAIL.COM